Biofilms in chronic rhinosinusitis: Pathophysiology and therapeutic strategies

Background: There is increasing evidence that biofilms are critical to the pathophysiology of chronic infections including chronic rhinosinusitis (CRS). Until relatively recently, our understanding of biofilms was limited. Recent advances in methods for biofilm identification and molecular biology h...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Judd H. Fastenberg, Wayne D. Hsueh, Ali Mustafa, Nadeem A. Akbar, Waleed M. Abuzeid
Formato: article
Lenguaje:EN
Publicado: KeAi Communications Co., Ltd. 2016
Materias:
Acceso en línea:https://doaj.org/article/1f88e4a5eeaf473ca3e83bed2e192382
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1f88e4a5eeaf473ca3e83bed2e192382
record_format dspace
spelling oai:doaj.org-article:1f88e4a5eeaf473ca3e83bed2e1923822021-12-02T14:20:55ZBiofilms in chronic rhinosinusitis: Pathophysiology and therapeutic strategies2095-881110.1016/j.wjorl.2016.03.002https://doaj.org/article/1f88e4a5eeaf473ca3e83bed2e1923822016-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S209588111630004Xhttps://doaj.org/toc/2095-8811Background: There is increasing evidence that biofilms are critical to the pathophysiology of chronic infections including chronic rhinosinusitis (CRS). Until relatively recently, our understanding of biofilms was limited. Recent advances in methods for biofilm identification and molecular biology have offered new insights into the role of biofilms in CRS. With these insights, investigators have begun to investigate novel therapeutic strategies that may disrupt or eradicate biofilms in CRS. Objective: This review seeks to explore the evidence implicating biofilms in CRS, discuss potential anti-biofilm therapeutic strategies, and suggest future directions for research. Results: The existing evidence strongly supports the role of biofilms in the pathogenesis of CRS. Several anti-biofilm therapies have been investigated for use in CRS and these are at variable stages of development. Generally, these strategies: 1) neutralize biofilm microbes; 2) disperse existing biofilms; or 3) disrupt quorum sensing. Several of the most promising anti-biofilm therapeutic strategies are reviewed. Conclusions: A better understanding of biofilm function and their contribution to the CRS disease process will be pivotal to the development of novel treatments that may augment and, potentially, redefine the CRS treatment paradigm. There is tremendous potential for future research. Keywords: Sinusitis, Biofilms, Anti-bacterial agents, Quorum sensing, Surface-active agents, Active immune response, Innate immune responseJudd H. FastenbergWayne D. HsuehAli MustafaNadeem A. AkbarWaleed M. AbuzeidKeAi Communications Co., Ltd.articleOtorhinolaryngologyRF1-547SurgeryRD1-811ENWorld Journal of Otorhinolaryngology-Head and Neck Surgery, Vol 2, Iss 4, Pp 219-229 (2016)
institution DOAJ
collection DOAJ
language EN
topic Otorhinolaryngology
RF1-547
Surgery
RD1-811
spellingShingle Otorhinolaryngology
RF1-547
Surgery
RD1-811
Judd H. Fastenberg
Wayne D. Hsueh
Ali Mustafa
Nadeem A. Akbar
Waleed M. Abuzeid
Biofilms in chronic rhinosinusitis: Pathophysiology and therapeutic strategies
description Background: There is increasing evidence that biofilms are critical to the pathophysiology of chronic infections including chronic rhinosinusitis (CRS). Until relatively recently, our understanding of biofilms was limited. Recent advances in methods for biofilm identification and molecular biology have offered new insights into the role of biofilms in CRS. With these insights, investigators have begun to investigate novel therapeutic strategies that may disrupt or eradicate biofilms in CRS. Objective: This review seeks to explore the evidence implicating biofilms in CRS, discuss potential anti-biofilm therapeutic strategies, and suggest future directions for research. Results: The existing evidence strongly supports the role of biofilms in the pathogenesis of CRS. Several anti-biofilm therapies have been investigated for use in CRS and these are at variable stages of development. Generally, these strategies: 1) neutralize biofilm microbes; 2) disperse existing biofilms; or 3) disrupt quorum sensing. Several of the most promising anti-biofilm therapeutic strategies are reviewed. Conclusions: A better understanding of biofilm function and their contribution to the CRS disease process will be pivotal to the development of novel treatments that may augment and, potentially, redefine the CRS treatment paradigm. There is tremendous potential for future research. Keywords: Sinusitis, Biofilms, Anti-bacterial agents, Quorum sensing, Surface-active agents, Active immune response, Innate immune response
format article
author Judd H. Fastenberg
Wayne D. Hsueh
Ali Mustafa
Nadeem A. Akbar
Waleed M. Abuzeid
author_facet Judd H. Fastenberg
Wayne D. Hsueh
Ali Mustafa
Nadeem A. Akbar
Waleed M. Abuzeid
author_sort Judd H. Fastenberg
title Biofilms in chronic rhinosinusitis: Pathophysiology and therapeutic strategies
title_short Biofilms in chronic rhinosinusitis: Pathophysiology and therapeutic strategies
title_full Biofilms in chronic rhinosinusitis: Pathophysiology and therapeutic strategies
title_fullStr Biofilms in chronic rhinosinusitis: Pathophysiology and therapeutic strategies
title_full_unstemmed Biofilms in chronic rhinosinusitis: Pathophysiology and therapeutic strategies
title_sort biofilms in chronic rhinosinusitis: pathophysiology and therapeutic strategies
publisher KeAi Communications Co., Ltd.
publishDate 2016
url https://doaj.org/article/1f88e4a5eeaf473ca3e83bed2e192382
work_keys_str_mv AT juddhfastenberg biofilmsinchronicrhinosinusitispathophysiologyandtherapeuticstrategies
AT waynedhsueh biofilmsinchronicrhinosinusitispathophysiologyandtherapeuticstrategies
AT alimustafa biofilmsinchronicrhinosinusitispathophysiologyandtherapeuticstrategies
AT nadeemaakbar biofilmsinchronicrhinosinusitispathophysiologyandtherapeuticstrategies
AT waleedmabuzeid biofilmsinchronicrhinosinusitispathophysiologyandtherapeuticstrategies
_version_ 1718391535825846272